News Release Article from  Innovation, Science and Economic Development Canada

Archived - Harper Government Announces New Personalized Health Research Projects Across Canada (Quebec)

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Latest projects will offer new hope for Canadian patients with debilitating diseases

Montréal, Quebec, March 26, 2013—Canadians with debilitating diseases will soon benefit from new personalized approaches to treatment thanks to researchers across the country and funding from the Harper Government. The Honourable Christian Paradis, Minister of Industry, today announced an investment of $38.8 million to support eight research projects in Quebec, as part of the national announcement made by the Honourable Gary Goodyear, Minister of State (Science and Technology), alongside Mike Lake, Parliamentary Secretary to the Minister of Industry.

"Our government recognizes that genomics is a science at the core of the global bio-economy and offers a myriad of social and economic benefits," said Minister Paradis. "Through our investments in applied genomics research, we are fostering Canada's innovative capability, while creating jobs and supporting long-term economic growth. These projects have the potential to transform the way health care is delivered in Canada, including improvements in clinical practice, better treatment and outcomes for patients and a more efficient, cost-effective health care system."

The projects are part of a major $150-million genomics and personalized health competition, a Genome Canada—Canadian Institutes of Health Research (CIHR) partnership.

Seventeen projects in total have been approved for funding, each valued in the range of $3 million to $13 million. The projects will focus on the application of genomics to tailor patient treatments and therapies in fields as diverse as epilepsy, autism, HIV/AIDS, cancer, cardiovascular disease, rare neurological diseases, and stroke, among others. The projects will be spearheaded by some of Canada's top researchers leading teams at academic institutions in Quebec. The research projects will examine:

  • Personalized medicine in the treatment of epilepsy (Patrick Cossette, Centre hospitalier universitaire de l'Université de Montréal)
  • Biomarkers for pediatric glioblastoma through genomics and epigenomics (Nada Jabado, McGill University Health Centre)
  • Personalized cancer immunotherapy (Claude Perreault, Hôpital Maisonneuve-Rosemont)
  • IBD Genomic Medicine Consortium (iGenoMed): Translating genetic discoveries into a personalized approach to treating inflammatory bowel diseases (John Rioux, Montreal Heart Institute)
  • PEGASUS: Personalized genomics for prenatal aneuploidy screening using maternal blood (François Rousseau, Université Laval)
  • Innovative chemogenomic tools to improve outcome in acute myeloid leukemia (Guy Sauvageau, Institute for Research in Immunology and Cancer)
  • Personalized risk stratification for prevention and early detection of breast cancer (Jacques Simard, Université Laval)
  • Personalized medicine strategies for molecular diagnostics and targeted therapeutics of cardiovascular diseases (Jean-Claude Tardif, Montreal Heart Institute)

In light of this competition, the Harper Government has invested approximately $45 million through Genome Canada, $24 million through CIHR and $2 million from the Cancer Stem Cell Consortium. The balance of funding is secured by regional Genome Centres from provincial governments, health charities, the private sector and other partners.

"What's exciting about these projects is that each one holds enormous potential for breakthroughs where there is a serious clinical need. Personalized health is about tailoring treatment and medicines to the individual patient based on their unique genetic makeup and this is only possible through advances in genomics research, " said Dr. Pierre Meulien, President and CEO of Genome Canada.

"Our partnership with Genome Canada and the Cancer Stem Cell Consortium is providing us with the ability to invest in a fashion that will impact many areas of health such as infection, cancer and rare diseases," said Dr. Alain Beaudet, President of CIHR. The projects announced today have the potential of allowing physicians to make better informed decisions and of providing patients with the best treatments and diagnoses possible."

To build on Genome Canada's achievements to date, Economic Action Plan 2013 proposes to provide $165 million in 2014–15 to support Genome Canada's multi-year strategic plan.

Since 2006, the Harper Government has provided nearly $9 billion in new funding for initiatives to support science, technology and the growth of innovative firms, helping to foster a world-class research and innovation system. Economic Action Plan 2013 is proposing to build on this strong foundation, helping to position Canada for sustainable, long-term economic prosperity and a higher quality of life for Canadians.

A complete list of the successful projects is available on Genome Canada's website at

For further information (media only), please contact:

Michèle-Jamali Paquette
Director of Communications
Office of the Honourable Gary Goodyear
Minister of State (Science and Technology)

Andrea Matyas
Communications Specialist
Genome Canada

Media Relations
Industry Canada

Search for related information by keyword

Innovation, Science and Economic Development Canada Science and Technology Economics and Industry Economic Action Plan

Date modified: